Skip to main content

Table 3 Associations of clinical variables with the annual change in total PAV

From: Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case–control study from the PARADIGM registry

 

Univariate

Multivariate

 

β

95% CI

P

β

95% CI

p

Age at enrollment, per 1 year increase

0.004

‒0.001 to 0.008

0.073

   

BMI, per 1 kg/m2 increase

‒0.006

‒0.019 to 0.006

0.317

   

SBP, per 10 mmHg increase

0.016

‒0.008 to 0.040

0.202

   

DBP, per 10 mmHg increase

0.018

‒0.023 to 0.058

0.394

   

Triglyceride, per 10 mg/dL increase

‒0.003

‒0.008 to 0.002

0.209

   

HDL-C, per 10 mg/dL increase

‒0.046

‒0.080 to -0.013

0.007

‒0.028

‒0.070 to 0.015

0.204

LDL-C, per 10 mg/dL increase

‒0.021

‒0.035 to -0.007

0.004

‒0.004

‒0.022 to 0.013

0.650

Creatinine, per 1 mg/dL increase

‒0.041

‒0.137 to 0.055

0.401

   

Hemoglobin A1C, per 1% increase

0.117

0.070–0.164

< 0.001

0.098

0.048–0.149

< 0.001

Statin use

0.118

0.034–0.201

0.006

0.078

‒0.036 to 0.192

0.176

  1. With the exception of age, independent variables were measured at follow-up CCTA.
  2. BMI body mass index, CCTA coronary computed tomography angiography, CI confidence interval, DBP diastolic blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, PAV percentage atheroma volume, SBP systolic blood pressure